Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2018Pharmacogenetics and Genomics

PharmGKB summary

View Full Paper
Ask AI
Bookmark
Share

Authors

CTCaroline F. ThornStanford MedicineDMDaniel J. MüllerTemple University HospitalRuss B. AltmanRuss B. AltmanStanford University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thorn et al. (2018) studied this question.

synapsesocial.com/papers/6a0d5ecb3dd857213409aa25https://doi.org/10.1097/fpc.0000000000000347
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antipsychotic Drugs Inhibit the Function of Breast Cancer Resistance Protein2008 · 65 citations
  2. 2Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non–protein‐bound concentrations2017 · 119 citations
  3. 3Pharmacokinetics of a Single Oral Dose of Clobazam in Patients with Liver Disease1994 · 20 citations